Tenvie Therapeutics

At Tenvie Therapeutics, every member of our team can point to our top-line corporate goals and articulate how what they do each day helps us achieve those objectives. No one knows this better than Tyler Chong-Kit - without his hard work, we literally would not be able to do the great science that drives our company! Tyler keeps the science humming, and his calm, collected demeanor is foundational to our Tenvie environment. When we asked Tyler what he was most excited for in the future and potential of Tenvie, he said "I'm excited to see the new challenges and growth of our team as we progress towards our goals." You're an integral part of that progress, Tyler!

At Tenvie Therapeutics, our In Vivo team sits at the center of all we do. They work cross-functionally with all our programs, and help form the bridge between Discovery and Development. Filomene Morrison is the newest addition to our In Vivo team - and with ~6 months under her belt at Tenvie, she has really found her sea legs! When we asked Filomene what motivated her to join this company, she said "from my first conversations with members of the team I could immediately tell that this was a group I wanted to be part of - this is a team with deep expertise, undying curiosity, and also genuine kindness, warmth, and support for one another." We're so glad you're here, Filomene!

We’re excited to share a significant scientific milestone: Tenvie has published our first preclinical data demonstrating that directly reducing CNS inflammation can lead to body weight reduction using a highly CNS-penetrant NLRP3 small molecule inhibitor. At Tenvie, we’re redefining what it means to pursue rigorous, mechanism-driven, drug discovery. Our latest work showcases how CNS-penetrant small molecules can open new therapeutic frontiers, enabling us to explore central NLRP3 inhibition as a potentially best-in-class approach to treating obesity. The learnings from this effort—particularly around CNS exposure as a driver of efficacy and the role of neuroinflammation in metabolic disease—are shaping Tenvie programs that target the complex interplay between inflammation, metabolism, and brain function. Read the full preprint: https://lnkd.in/eQhyy97z #Neuroscience #Obesity #Neuroinflammation #DrugDiscovery #NLRP3 #TeamTenvie

Tenvie Therapeutics is thrilled to announce the newest addition to our team! Jennifer B. has just joined Tenvie as Director, Clinical Operations. Welcome to the team, Jenn!

At Tenvie Therapeutics, we know that 'behind-the-scenes' roles are critical to smooth company functioning. Maya Frattini keeps our team aligned, organized, and aimed in the right direction. When we asked Maya her favorite part of being on the Tenvie team, she said "The people and culture! Everyone here is so approachable, encouraging, and they genuinely care about each other and working toward the same goals." Thank you for being part of our team, Maya!

It's exciting times at Tenvie Therapeutics - announcing a new team member! We're thrilled to welcome Lara Ibrahim to the team!

Tenvie Therapeutics is so excited to announce a new addition to our Clin Ops team! Welcome, Shirley T.

At Tenvie Therapeutics, technology is central to all we do. We are so excited to announce that Samuel M. has joined Tenvie as our new IT Associate! He's a great addition to our team.

As Tenvie Therapeutics expands our clinical development capabilities, we are adding some truly exceptional talent to our team. We are so excited to announce Bill Avery has joined Tenvie! He's a crucial component to our Clin Dev build, and we are fortunate to have him on the team.

Meghan Kerrisk Campbell is a bridge-builder at Tenvie Therapeutics - she links functions, translates perspectives, and brings people together. When asked what excites her most about the future and potential of Tenvie, Meghan said "we have multiple small molecules right on the cusp of early human trials. I am excited for the opportunity to put these molecules to the test and make an impact on patient’s lives." Thank you for being part of our team, Meghan!